Science Explorer Back to mapMap
Discussion
Researcher · Minnesota Oncology · United States

THOMAS T. AMATRUDA

THOMAS T. AMATRUDA publishes mostly in Oncology, Molecular Biology and Immunology, on topics such as CAR-T cell therapy research, Cutaneous Melanoma Detection and Management and Immunotherapy and Immune Responses.

OpenAlex
World rank
#148,967
of 7,710,434 ranked researchers
Rank in United States
#56,187
of 1,627,098
Works
82
Citations
8.1k
Citations per work
99.2
h-index
40
i10-index 53Top 6.3% in Oncology
THOMAS T. AMATRUDA

What does THOMAS T. AMATRUDA research?

THOMAS T. AMATRUDA's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (10%).

Health Sciences: 30 works · 37.0% of their workMedicine: 30 works · 37.0% of their workOncology: 23 works · 27.8% of their workEndocrinology, Diabetes and Metabolism: 4 works · 4.8% of their workPulmonary and Respiratory Medicine: 4 works · 4.4% of their workLife Sciences: 29 works · 34.8% of their workBiochemistry, Genetics and Molecular Biology: 20 works · 24.7% of their workMolecular Biology: 13 works · 15.4% of their workGenetics: 8 works · 9.3% of their workImmunology and Microbiology: 8 works · 10.1% of their workImmunology: 8 works · 10.1% of their workEverything else: 23 works · 28.2% of their workTHEIR WORKTHOMAS T.AMATRUDA82works
Life Sciences35%Health Sciences37%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3037.0%
    1. Biochemistry, Genetics and Molecular Biology2024.7%
    2. Immunology and Microbiology810.1%
  3. Everything else2328.2%
  1. 1Oncology28% of their works
  2. 2Molecular Biology15% of their works
  3. 3Immunology10% of their works
  4. 4Genetics9% of their works
  5. 5Endocrinology, Diabetes and Metabolism5% of their works
  6. 6Pulmonary and Respiratory Medicine4% of their works

Research topics

Which keywords describe THOMAS T. AMATRUDA's research?

The keywords of their largest research topics: Immunotherapy, Cancer Immunotherapy, Melanoma, Tumor Regression, CAR T Cells, Chimeric Antigen Receptor, Gene Therapy and Dermoscopy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Immunotherapy604 topics
  2. Cancer Immunotherapy452 topics
  3. Melanoma372 topics
  4. Tumor Regression332 topics
  5. CAR T Cells261 topic
  6. Chimeric Antigen Receptor261 topic
  7. Gene Therapy242 topics
  8. Dermoscopy201 topic
  9. Skin Cancer201 topic
  10. Dendritic Cells191 topic
  11. Immunity191 topic
  12. AAV171 topic
  13. BRAF gene171 topic
  14. MAP Kinase171 topic
  15. Viral Vectors171 topic
  16. Immune Checkpoint Blockade81 topic
  17. PD-1 and PD-L181 topic
  18. Bacterial Therapy71 topic
  19. Brain Metastases71 topic
  20. Radiosurgery71 topic
  21. Tumor Targeting71 topic

Where does THOMAS T. AMATRUDA work?

THOMAS T. AMATRUDA's main affiliation in the publication record is Minnesota Oncology, United States.

How many publications and citations does THOMAS T. AMATRUDA have?

OpenAlex counts 82 works and 8,131 citations for THOMAS T. AMATRUDA, an h-index of 40, ranking #148,967 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about THOMAS T. AMATRUDA. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.